----
Current Valuation
-64.78xP/E
HK$39.46Stock price
HK$-0.61Earnings per share
-64.78xP/E
Stock priceHK$39.46Earnings per shareHK$-0.61
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.70x
011223344
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.70x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
06872HKTENNOR THERAP-B | -77.91x | -- | HK$13.22B |
02335HKMICOT PHARMA-B | -64.78x | -- | HK$13.09B |
02630HKVIGONVITA-B | -25.19x | -- | HK$9.92B |
02575HKXUANZHUBIO-B | -26.68x | -- | HK$7.25B |
09637HKALEBUND-B | -- | -- | HK$7.68B |
00570HKTRAD CHI MED | -18.35x | 310.14% | HK$6.95B |
01477HKOCUMENSION-B | -20.31x | 120.44% | HK$3.57B |
01349HKFUDANZHANGJIANG | -13.99x | -- | HK$2.42B |
06996HKANTENGENE-B | -8.59x | 234.26% | HK$2.28B |
06622HKZHAOKE OPHTH-B | -5.91x | -- | HK$1.37B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
